AGP Executive Report
Last update: 6 hours agoCardiovascular Health (UAE): A UAE family-medicine doctor says daily coffee may protect heart health if people stick to 1–5 cups a day (max 5), avoid excess, and follow the right routine—citing links to lower insulin resistance and less arterial inflammation. Prison Health & Rights (Iran): IranWire reports a Baha’i prisoner in Shiraz, Roya Thabit, is still denied medical furlough and proper care after a June injury, with oxygen levels reportedly dropping during a later crisis. Clinical Research (Cardiology): Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan (TNX-103) in PH-HFpEF missed its main walking-distance goal, though subgroup results and biomarkers suggest benefit in patients with higher disease burden. Clinical Research (Lung Disease): Grifols says follow-up is complete for SPARTA, its Phase 3 outcomes study of Prolastin-C for emphysema due to alpha-1 antitrypsin deficiency, with top-line results expected by end-2026. Health Security (Ukraine): WHO says a Russian strike destroyed its Dnipro humanitarian warehouse, disrupting emergency medical supplies and renewing calls to protect healthcare infrastructure. Conflict & Health (Yemen): dpa reports renewed shelling in western Yemen after Houthi drone and missile attacks on Mokha, with civilians among the injured. Biotech & Policy (GCC): Riyadh is set to host the Riyadh Global Medical Biotech Summit 2026, bringing global biotech leaders together as regional health innovation accelerates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
